These initial studies confirmed the concept that next to high-risk genes, like BRCA1/2 and MMR genes, other genes also contribute to the familial cancer predisposition and undoubtedly demonstrated some potential of NGS to identify such genetic causes among families that test negative for mutations in high-risk genes using traditional methods. This evidence concerns the gene BRCA1 and cancer.